NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
-
Company News
-
Aug 04, 2025
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketingNKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
Latestinsights and stories
-
Company NewsNKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!
Dec 05, 2025 -
Company NewsNKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketing
Dec 03, 2025 -
Company NewsNKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
Oct 21, 2025 -
Company NewsNKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
Oct 17, 2025
